COVID-19 Impact on Global Embolic Agents Market Insights, Forecast to 2026
Embolic Agent is a material used to block off blood flow through a vessel.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Embolic Agents market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Embolic Agents industry.
Based on our recent survey, we have several different scenarios about the Embolic Agents YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Embolic Agents will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Embolic Agents market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Embolic Agents market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Embolic Agents market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Production and Pricing Analyses
Readers are provided with deeper production analysis, import and export analysis, and pricing analysis for the global Embolic Agents market. As part of production analysis, the report offers accurate statistics and figures for production capacity, production volume by region, and global production and production by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for price by manufacturer and price by region for the period 2015-2020 and price by each type segment for the period 2015-2026. The import and export analysis for the global Embolic Agents market has been provided based on region.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Embolic Agents market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of volume for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Embolic Agents market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Embolic Agents market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Embolic Agents market.
The following manufacturers are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Embolic Agents market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Embolic Agents industry.
Based on our recent survey, we have several different scenarios about the Embolic Agents YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Embolic Agents will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Embolic Agents market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Embolic Agents market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Embolic Agents market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Production and Pricing Analyses
Readers are provided with deeper production analysis, import and export analysis, and pricing analysis for the global Embolic Agents market. As part of production analysis, the report offers accurate statistics and figures for production capacity, production volume by region, and global production and production by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for price by manufacturer and price by region for the period 2015-2020 and price by each type segment for the period 2015-2026. The import and export analysis for the global Embolic Agents market has been provided based on region.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Embolic Agents market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of volume for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Embolic Agents market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Embolic Agents market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Embolic Agents market.
The following manufacturers are covered in this report:
- Medtronic
- Terumo
- Boston Scientific
- Merit Medical
- Johnson & Johnson
- GEM Italy
- IMBiotechnologies Ltd?IMB?
- Emboflu
- BTG
- Cook Medical
- Liquid Embolic Agents
- Particulate Embolic Agents
- Others
- Occlude Bleeding
- Oncotherapy
- Malignant Hypertension
- Others
1 STUDY COVERAGE
1.1 Embolic Agents Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Embolic Agents Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Embolic Agents Market Size Growth Rate by Type
1.4.2 Liquid Embolic Agents
1.4.3 Particulate Embolic Agents
1.4.4 Others
1.5 Market by Application
1.5.1 Global Embolic Agents Market Size Growth Rate by Application
1.5.2 Occlude Bleeding
1.5.3 Oncotherapy
1.5.4 Malignant Hypertension
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Embolic Agents Industry Impact
1.6.1 How the Covid-19 is Affecting the Embolic Agents Industry
1.6.1.1 Embolic Agents Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Embolic Agents Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Embolic Agents Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Embolic Agents Market Size Estimates and Forecasts
2.1.1 Global Embolic Agents Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Embolic Agents Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Embolic Agents Production Estimates and Forecasts 2015-2026
2.2 Global Embolic Agents Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Embolic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Embolic Agents Manufacturers Geographical Distribution
2.4 Key Trends for Embolic Agents Markets & Products
2.5 Primary Interviews with Key Embolic Agents Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Embolic Agents Manufacturers by Production Capacity
3.1.1 Global Top Embolic Agents Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Embolic Agents Manufacturers by Production (2015-2020)
3.1.3 Global Top Embolic Agents Manufacturers Market Share by Production
3.2 Global Top Embolic Agents Manufacturers by Revenue
3.2.1 Global Top Embolic Agents Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Embolic Agents Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Embolic Agents Revenue in 2019
3.3 Global Embolic Agents Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 EMBOLIC AGENTS PRODUCTION BY REGIONS
4.1 Global Embolic Agents Historic Market Facts & Figures by Regions
4.1.1 Global Top Embolic Agents Regions by Production (2015-2020)
4.1.2 Global Top Embolic Agents Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Embolic Agents Production (2015-2020)
4.2.2 North America Embolic Agents Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Embolic Agents Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Embolic Agents Production (2015-2020)
4.3.2 Europe Embolic Agents Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Embolic Agents Import & Export (2015-2020)
4.4 China
4.4.1 China Embolic Agents Production (2015-2020)
4.4.2 China Embolic Agents Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Embolic Agents Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Embolic Agents Production (2015-2020)
4.5.2 Japan Embolic Agents Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Embolic Agents Import & Export (2015-2020)
5 EMBOLIC AGENTS CONSUMPTION BY REGION
5.1 Global Top Embolic Agents Regions by Consumption
5.1.1 Global Top Embolic Agents Regions by Consumption (2015-2020)
5.1.2 Global Top Embolic Agents Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Embolic Agents Consumption by Application
5.2.2 North America Embolic Agents Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Embolic Agents Consumption by Application
5.3.2 Europe Embolic Agents Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Embolic Agents Consumption by Application
5.4.2 Asia Pacific Embolic Agents Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Embolic Agents Consumption by Application
5.5.2 Central & South America Embolic Agents Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Embolic Agents Consumption by Application
5.6.2 Middle East and Africa Embolic Agents Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Embolic Agents Market Size by Type (2015-2020)
6.1.1 Global Embolic Agents Production by Type (2015-2020)
6.1.2 Global Embolic Agents Revenue by Type (2015-2020)
6.1.3 Embolic Agents Price by Type (2015-2020)
6.2 Global Embolic Agents Market Forecast by Type (2021-2026)
6.2.1 Global Embolic Agents Production Forecast by Type (2021-2026)
6.2.2 Global Embolic Agents Revenue Forecast by Type (2021-2026)
6.2.3 Global Embolic Agents Price Forecast by Type (2021-2026)
6.3 Global Embolic Agents Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Embolic Agents Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Embolic Agents Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 Medtronic
8.1.1 Medtronic Corporation Information
8.1.2 Medtronic Overview and Its Total Revenue
8.1.3 Medtronic Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Medtronic Product Description
8.1.5 Medtronic Recent Development
8.2 Terumo
8.2.1 Terumo Corporation Information
8.2.2 Terumo Overview and Its Total Revenue
8.2.3 Terumo Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Terumo Product Description
8.2.5 Terumo Recent Development
8.3 Boston Scientific
8.3.1 Boston Scientific Corporation Information
8.3.2 Boston Scientific Overview and Its Total Revenue
8.3.3 Boston Scientific Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Boston Scientific Product Description
8.3.5 Boston Scientific Recent Development
8.4 Merit Medical
8.4.1 Merit Medical Corporation Information
8.4.2 Merit Medical Overview and Its Total Revenue
8.4.3 Merit Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Merit Medical Product Description
8.4.5 Merit Medical Recent Development
8.5 Johnson & Johnson
8.5.1 Johnson & Johnson Corporation Information
8.5.2 Johnson & Johnson Overview and Its Total Revenue
8.5.3 Johnson & Johnson Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Johnson & Johnson Product Description
8.5.5 Johnson & Johnson Recent Development
8.6 GEM Italy
8.6.1 GEM Italy Corporation Information
8.6.2 GEM Italy Overview and Its Total Revenue
8.6.3 GEM Italy Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 GEM Italy Product Description
8.6.5 GEM Italy Recent Development
8.7 IMBiotechnologies Ltd?IMB?
8.7.1 IMBiotechnologies Ltd?IMB? Corporation Information
8.7.2 IMBiotechnologies Ltd?IMB? Overview and Its Total Revenue
8.7.3 IMBiotechnologies Ltd?IMB? Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 IMBiotechnologies Ltd?IMB? Product Description
8.7.5 IMBiotechnologies Ltd?IMB? Recent Development
8.8 Emboflu
8.8.1 Emboflu Corporation Information
8.8.2 Emboflu Overview and Its Total Revenue
8.8.3 Emboflu Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Emboflu Product Description
8.8.5 Emboflu Recent Development
8.9 BTG
8.9.1 BTG Corporation Information
8.9.2 BTG Overview and Its Total Revenue
8.9.3 BTG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 BTG Product Description
8.9.5 BTG Recent Development
8.10 Cook Medical
8.10.1 Cook Medical Corporation Information
8.10.2 Cook Medical Overview and Its Total Revenue
8.10.3 Cook Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Cook Medical Product Description
8.10.5 Cook Medical Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Embolic Agents Regions Forecast by Revenue (2021-2026)
9.2 Global Top Embolic Agents Regions Forecast by Production (2021-2026)
9.3 Key Embolic Agents Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 EMBOLIC AGENTS CONSUMPTION FORECAST BY REGION
10.1 Global Embolic Agents Consumption Forecast by Region (2021-2026)
10.2 North America Embolic Agents Consumption Forecast by Region (2021-2026)
10.3 Europe Embolic Agents Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Embolic Agents Consumption Forecast by Region (2021-2026)
10.5 Latin America Embolic Agents Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Embolic Agents Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Embolic Agents Sales Channels
11.2.2 Embolic Agents Distributors
11.3 Embolic Agents Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL EMBOLIC AGENTS STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Embolic Agents Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Embolic Agents Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Embolic Agents Market Size Growth Rate by Type
1.4.2 Liquid Embolic Agents
1.4.3 Particulate Embolic Agents
1.4.4 Others
1.5 Market by Application
1.5.1 Global Embolic Agents Market Size Growth Rate by Application
1.5.2 Occlude Bleeding
1.5.3 Oncotherapy
1.5.4 Malignant Hypertension
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Embolic Agents Industry Impact
1.6.1 How the Covid-19 is Affecting the Embolic Agents Industry
1.6.1.1 Embolic Agents Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Embolic Agents Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Embolic Agents Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Embolic Agents Market Size Estimates and Forecasts
2.1.1 Global Embolic Agents Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Embolic Agents Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Embolic Agents Production Estimates and Forecasts 2015-2026
2.2 Global Embolic Agents Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Embolic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Embolic Agents Manufacturers Geographical Distribution
2.4 Key Trends for Embolic Agents Markets & Products
2.5 Primary Interviews with Key Embolic Agents Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Embolic Agents Manufacturers by Production Capacity
3.1.1 Global Top Embolic Agents Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Embolic Agents Manufacturers by Production (2015-2020)
3.1.3 Global Top Embolic Agents Manufacturers Market Share by Production
3.2 Global Top Embolic Agents Manufacturers by Revenue
3.2.1 Global Top Embolic Agents Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Embolic Agents Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Embolic Agents Revenue in 2019
3.3 Global Embolic Agents Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 EMBOLIC AGENTS PRODUCTION BY REGIONS
4.1 Global Embolic Agents Historic Market Facts & Figures by Regions
4.1.1 Global Top Embolic Agents Regions by Production (2015-2020)
4.1.2 Global Top Embolic Agents Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Embolic Agents Production (2015-2020)
4.2.2 North America Embolic Agents Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Embolic Agents Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Embolic Agents Production (2015-2020)
4.3.2 Europe Embolic Agents Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Embolic Agents Import & Export (2015-2020)
4.4 China
4.4.1 China Embolic Agents Production (2015-2020)
4.4.2 China Embolic Agents Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Embolic Agents Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Embolic Agents Production (2015-2020)
4.5.2 Japan Embolic Agents Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Embolic Agents Import & Export (2015-2020)
5 EMBOLIC AGENTS CONSUMPTION BY REGION
5.1 Global Top Embolic Agents Regions by Consumption
5.1.1 Global Top Embolic Agents Regions by Consumption (2015-2020)
5.1.2 Global Top Embolic Agents Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Embolic Agents Consumption by Application
5.2.2 North America Embolic Agents Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Embolic Agents Consumption by Application
5.3.2 Europe Embolic Agents Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Embolic Agents Consumption by Application
5.4.2 Asia Pacific Embolic Agents Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Embolic Agents Consumption by Application
5.5.2 Central & South America Embolic Agents Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Embolic Agents Consumption by Application
5.6.2 Middle East and Africa Embolic Agents Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Embolic Agents Market Size by Type (2015-2020)
6.1.1 Global Embolic Agents Production by Type (2015-2020)
6.1.2 Global Embolic Agents Revenue by Type (2015-2020)
6.1.3 Embolic Agents Price by Type (2015-2020)
6.2 Global Embolic Agents Market Forecast by Type (2021-2026)
6.2.1 Global Embolic Agents Production Forecast by Type (2021-2026)
6.2.2 Global Embolic Agents Revenue Forecast by Type (2021-2026)
6.2.3 Global Embolic Agents Price Forecast by Type (2021-2026)
6.3 Global Embolic Agents Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Embolic Agents Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Embolic Agents Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 Medtronic
8.1.1 Medtronic Corporation Information
8.1.2 Medtronic Overview and Its Total Revenue
8.1.3 Medtronic Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Medtronic Product Description
8.1.5 Medtronic Recent Development
8.2 Terumo
8.2.1 Terumo Corporation Information
8.2.2 Terumo Overview and Its Total Revenue
8.2.3 Terumo Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Terumo Product Description
8.2.5 Terumo Recent Development
8.3 Boston Scientific
8.3.1 Boston Scientific Corporation Information
8.3.2 Boston Scientific Overview and Its Total Revenue
8.3.3 Boston Scientific Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Boston Scientific Product Description
8.3.5 Boston Scientific Recent Development
8.4 Merit Medical
8.4.1 Merit Medical Corporation Information
8.4.2 Merit Medical Overview and Its Total Revenue
8.4.3 Merit Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Merit Medical Product Description
8.4.5 Merit Medical Recent Development
8.5 Johnson & Johnson
8.5.1 Johnson & Johnson Corporation Information
8.5.2 Johnson & Johnson Overview and Its Total Revenue
8.5.3 Johnson & Johnson Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Johnson & Johnson Product Description
8.5.5 Johnson & Johnson Recent Development
8.6 GEM Italy
8.6.1 GEM Italy Corporation Information
8.6.2 GEM Italy Overview and Its Total Revenue
8.6.3 GEM Italy Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 GEM Italy Product Description
8.6.5 GEM Italy Recent Development
8.7 IMBiotechnologies Ltd?IMB?
8.7.1 IMBiotechnologies Ltd?IMB? Corporation Information
8.7.2 IMBiotechnologies Ltd?IMB? Overview and Its Total Revenue
8.7.3 IMBiotechnologies Ltd?IMB? Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 IMBiotechnologies Ltd?IMB? Product Description
8.7.5 IMBiotechnologies Ltd?IMB? Recent Development
8.8 Emboflu
8.8.1 Emboflu Corporation Information
8.8.2 Emboflu Overview and Its Total Revenue
8.8.3 Emboflu Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Emboflu Product Description
8.8.5 Emboflu Recent Development
8.9 BTG
8.9.1 BTG Corporation Information
8.9.2 BTG Overview and Its Total Revenue
8.9.3 BTG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 BTG Product Description
8.9.5 BTG Recent Development
8.10 Cook Medical
8.10.1 Cook Medical Corporation Information
8.10.2 Cook Medical Overview and Its Total Revenue
8.10.3 Cook Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Cook Medical Product Description
8.10.5 Cook Medical Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Embolic Agents Regions Forecast by Revenue (2021-2026)
9.2 Global Top Embolic Agents Regions Forecast by Production (2021-2026)
9.3 Key Embolic Agents Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 EMBOLIC AGENTS CONSUMPTION FORECAST BY REGION
10.1 Global Embolic Agents Consumption Forecast by Region (2021-2026)
10.2 North America Embolic Agents Consumption Forecast by Region (2021-2026)
10.3 Europe Embolic Agents Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Embolic Agents Consumption Forecast by Region (2021-2026)
10.5 Latin America Embolic Agents Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Embolic Agents Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Embolic Agents Sales Channels
11.2.2 Embolic Agents Distributors
11.3 Embolic Agents Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL EMBOLIC AGENTS STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
LIST OF TABLES
Table 1. Embolic Agents Key Market Segments in This Study
Table 2. Ranking of Global Top Embolic Agents Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Embolic Agents Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Liquid Embolic Agents
Table 5. Major Manufacturers of Particulate Embolic Agents
Table 6. Major Manufacturers of Others
Table 7. COVID-19 Impact Global Market: (Four Embolic Agents Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Embolic Agents Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Embolic Agents Players to Combat Covid-19 Impact
Table 12. Global Embolic Agents Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Embolic Agents Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Embolic Agents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Embolic Agents as of 2019)
Table 16. Embolic Agents Manufacturing Base Distribution and Headquarters
Table 17. Manufacturers Embolic Agents Product Offered
Table 18. Date of Manufacturers Enter into Embolic Agents Market
Table 19. Key Trends for Embolic Agents Markets & Products
Table 20. Main Points Interviewed from Key Embolic Agents Players
Table 21. Global Embolic Agents Production Capacity by Manufacturers (2015-2020) (K Units)
Table 22. Global Embolic Agents Production Share by Manufacturers (2015-2020)
Table 23. Embolic Agents Revenue by Manufacturers (2015-2020) (Million US$)
Table 24. Embolic Agents Revenue Share by Manufacturers (2015-2020)
Table 25. Embolic Agents Price by Manufacturers 2015-2020 (USD/Unit)
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Embolic Agents Production by Regions (2015-2020) (K Units)
Table 28. Global Embolic Agents Production Market Share by Regions (2015-2020)
Table 29. Global Embolic Agents Revenue by Regions (2015-2020) (US$ Million)
Table 30. Global Embolic Agents Revenue Market Share by Regions (2015-2020)
Table 31. Key Embolic Agents Players in North America
Table 32. Import & Export of Embolic Agents in North America (K Units)
Table 33. Key Embolic Agents Players in Europe
Table 34. Import & Export of Embolic Agents in Europe (K Units)
Table 35. Key Embolic Agents Players in China
Table 36. Import & Export of Embolic Agents in China (K Units)
Table 37. Key Embolic Agents Players in Japan
Table 38. Import & Export of Embolic Agents in Japan (K Units)
Table 39. Global Embolic Agents Consumption by Regions (2015-2020) (K Units)
Table 40. Global Embolic Agents Consumption Market Share by Regions (2015-2020)
Table 41. North America Embolic Agents Consumption by Application (2015-2020) (K Units)
Table 42. North America Embolic Agents Consumption by Countries (2015-2020) (K Units)
Table 43. Europe Embolic Agents Consumption by Application (2015-2020) (K Units)
Table 44. Europe Embolic Agents Consumption by Countries (2015-2020) (K Units)
Table 45. Asia Pacific Embolic Agents Consumption by Application (2015-2020) (K Units)
Table 46. Asia Pacific Embolic Agents Consumption Market Share by Application (2015-2020) (K Units)
Table 47. Asia Pacific Embolic Agents Consumption by Regions (2015-2020) (K Units)
Table 48. Latin America Embolic Agents Consumption by Application (2015-2020) (K Units)
Table 49. Latin America Embolic Agents Consumption by Countries (2015-2020) (K Units)
Table 50. Middle East and Africa Embolic Agents Consumption by Application (2015-2020) (K Units)
Table 51. Middle East and Africa Embolic Agents Consumption by Countries (2015-2020) (K Units)
Table 52. Global Embolic Agents Production by Type (2015-2020) (K Units)
Table 53. Global Embolic Agents Production Share by Type (2015-2020)
Table 54. Global Embolic Agents Revenue by Type (2015-2020) (Million US$)
Table 55. Global Embolic Agents Revenue Share by Type (2015-2020)
Table 56. Embolic Agents Price by Type 2015-2020 (USD/Unit)
Table 57. Global Embolic Agents Consumption by Application (2015-2020) (K Units)
Table 58. Global Embolic Agents Consumption by Application (2015-2020) (K Units)
Table 59. Global Embolic Agents Consumption Share by Application (2015-2020)
Table 60. Medtronic Corporation Information
Table 61. Medtronic Description and Major Businesses
Table 62. Medtronic Embolic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 63. Medtronic Product
Table 64. Medtronic Recent Development
Table 65. Terumo Corporation Information
Table 66. Terumo Description and Major Businesses
Table 67. Terumo Embolic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 68. Terumo Product
Table 69. Terumo Recent Development
Table 70. Boston Scientific Corporation Information
Table 71. Boston Scientific Description and Major Businesses
Table 72. Boston Scientific Embolic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Boston Scientific Product
Table 74. Boston Scientific Recent Development
Table 75. Merit Medical Corporation Information
Table 76. Merit Medical Description and Major Businesses
Table 77. Merit Medical Embolic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Merit Medical Product
Table 79. Merit Medical Recent Development
Table 80. Johnson & Johnson Corporation Information
Table 81. Johnson & Johnson Description and Major Businesses
Table 82. Johnson & Johnson Embolic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Johnson & Johnson Product
Table 84. Johnson & Johnson Recent Development
Table 85. GEM Italy Corporation Information
Table 86. GEM Italy Description and Major Businesses
Table 87. GEM Italy Embolic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. GEM Italy Product
Table 89. GEM Italy Recent Development
Table 90. IMBiotechnologies Ltd?IMB? Corporation Information
Table 91. IMBiotechnologies Ltd?IMB? Description and Major Businesses
Table 92. IMBiotechnologies Ltd?IMB? Embolic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. IMBiotechnologies Ltd?IMB? Product
Table 94. IMBiotechnologies Ltd?IMB? Recent Development
Table 95. Emboflu Corporation Information
Table 96. Emboflu Description and Major Businesses
Table 97. Emboflu Embolic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Emboflu Product
Table 99. Emboflu Recent Development
Table 100. BTG Corporation Information
Table 101. BTG Description and Major Businesses
Table 102. BTG Embolic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. BTG Product
Table 104. BTG Recent Development
Table 105. Cook Medical Corporation Information
Table 106. Cook Medical Description and Major Businesses
Table 107. Cook Medical Embolic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Cook Medical Product
Table 109. Cook Medical Recent Development
Table 110. Global Embolic Agents Revenue Forecast by Region (2021-2026) (Million US$)
Table 111. Global Embolic Agents Production Forecast by Regions (2021-2026) (K Units)
Table 112. Global Embolic Agents Production Forecast by Type (2021-2026) (K Units)
Table 113. Global Embolic Agents Revenue Forecast by Type (2021-2026) (Million US$)
Table 114. North America Embolic Agents Consumption Forecast by Regions (2021-2026) (K Units)
Table 115. Europe Embolic Agents Consumption Forecast by Regions (2021-2026) (K Units)
Table 116. Asia Pacific Embolic Agents Consumption Forecast by Regions (2021-2026) (K Units)
Table 117. Latin America Embolic Agents Consumption Forecast by Regions (2021-2026) (K Units)
Table 118. Middle East and Africa Embolic Agents Consumption Forecast by Regions (2021-2026) (K Units)
Table 119. Embolic Agents Distributors List
Table 120. Embolic Agents Customers List
Table 121. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 122. Key Challenges
Table 123. Market Risks
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
Table 1. Embolic Agents Key Market Segments in This Study
Table 2. Ranking of Global Top Embolic Agents Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Embolic Agents Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Liquid Embolic Agents
Table 5. Major Manufacturers of Particulate Embolic Agents
Table 6. Major Manufacturers of Others
Table 7. COVID-19 Impact Global Market: (Four Embolic Agents Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Embolic Agents Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Embolic Agents Players to Combat Covid-19 Impact
Table 12. Global Embolic Agents Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Embolic Agents Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Embolic Agents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Embolic Agents as of 2019)
Table 16. Embolic Agents Manufacturing Base Distribution and Headquarters
Table 17. Manufacturers Embolic Agents Product Offered
Table 18. Date of Manufacturers Enter into Embolic Agents Market
Table 19. Key Trends for Embolic Agents Markets & Products
Table 20. Main Points Interviewed from Key Embolic Agents Players
Table 21. Global Embolic Agents Production Capacity by Manufacturers (2015-2020) (K Units)
Table 22. Global Embolic Agents Production Share by Manufacturers (2015-2020)
Table 23. Embolic Agents Revenue by Manufacturers (2015-2020) (Million US$)
Table 24. Embolic Agents Revenue Share by Manufacturers (2015-2020)
Table 25. Embolic Agents Price by Manufacturers 2015-2020 (USD/Unit)
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Embolic Agents Production by Regions (2015-2020) (K Units)
Table 28. Global Embolic Agents Production Market Share by Regions (2015-2020)
Table 29. Global Embolic Agents Revenue by Regions (2015-2020) (US$ Million)
Table 30. Global Embolic Agents Revenue Market Share by Regions (2015-2020)
Table 31. Key Embolic Agents Players in North America
Table 32. Import & Export of Embolic Agents in North America (K Units)
Table 33. Key Embolic Agents Players in Europe
Table 34. Import & Export of Embolic Agents in Europe (K Units)
Table 35. Key Embolic Agents Players in China
Table 36. Import & Export of Embolic Agents in China (K Units)
Table 37. Key Embolic Agents Players in Japan
Table 38. Import & Export of Embolic Agents in Japan (K Units)
Table 39. Global Embolic Agents Consumption by Regions (2015-2020) (K Units)
Table 40. Global Embolic Agents Consumption Market Share by Regions (2015-2020)
Table 41. North America Embolic Agents Consumption by Application (2015-2020) (K Units)
Table 42. North America Embolic Agents Consumption by Countries (2015-2020) (K Units)
Table 43. Europe Embolic Agents Consumption by Application (2015-2020) (K Units)
Table 44. Europe Embolic Agents Consumption by Countries (2015-2020) (K Units)
Table 45. Asia Pacific Embolic Agents Consumption by Application (2015-2020) (K Units)
Table 46. Asia Pacific Embolic Agents Consumption Market Share by Application (2015-2020) (K Units)
Table 47. Asia Pacific Embolic Agents Consumption by Regions (2015-2020) (K Units)
Table 48. Latin America Embolic Agents Consumption by Application (2015-2020) (K Units)
Table 49. Latin America Embolic Agents Consumption by Countries (2015-2020) (K Units)
Table 50. Middle East and Africa Embolic Agents Consumption by Application (2015-2020) (K Units)
Table 51. Middle East and Africa Embolic Agents Consumption by Countries (2015-2020) (K Units)
Table 52. Global Embolic Agents Production by Type (2015-2020) (K Units)
Table 53. Global Embolic Agents Production Share by Type (2015-2020)
Table 54. Global Embolic Agents Revenue by Type (2015-2020) (Million US$)
Table 55. Global Embolic Agents Revenue Share by Type (2015-2020)
Table 56. Embolic Agents Price by Type 2015-2020 (USD/Unit)
Table 57. Global Embolic Agents Consumption by Application (2015-2020) (K Units)
Table 58. Global Embolic Agents Consumption by Application (2015-2020) (K Units)
Table 59. Global Embolic Agents Consumption Share by Application (2015-2020)
Table 60. Medtronic Corporation Information
Table 61. Medtronic Description and Major Businesses
Table 62. Medtronic Embolic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 63. Medtronic Product
Table 64. Medtronic Recent Development
Table 65. Terumo Corporation Information
Table 66. Terumo Description and Major Businesses
Table 67. Terumo Embolic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 68. Terumo Product
Table 69. Terumo Recent Development
Table 70. Boston Scientific Corporation Information
Table 71. Boston Scientific Description and Major Businesses
Table 72. Boston Scientific Embolic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Boston Scientific Product
Table 74. Boston Scientific Recent Development
Table 75. Merit Medical Corporation Information
Table 76. Merit Medical Description and Major Businesses
Table 77. Merit Medical Embolic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Merit Medical Product
Table 79. Merit Medical Recent Development
Table 80. Johnson & Johnson Corporation Information
Table 81. Johnson & Johnson Description and Major Businesses
Table 82. Johnson & Johnson Embolic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Johnson & Johnson Product
Table 84. Johnson & Johnson Recent Development
Table 85. GEM Italy Corporation Information
Table 86. GEM Italy Description and Major Businesses
Table 87. GEM Italy Embolic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. GEM Italy Product
Table 89. GEM Italy Recent Development
Table 90. IMBiotechnologies Ltd?IMB? Corporation Information
Table 91. IMBiotechnologies Ltd?IMB? Description and Major Businesses
Table 92. IMBiotechnologies Ltd?IMB? Embolic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. IMBiotechnologies Ltd?IMB? Product
Table 94. IMBiotechnologies Ltd?IMB? Recent Development
Table 95. Emboflu Corporation Information
Table 96. Emboflu Description and Major Businesses
Table 97. Emboflu Embolic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Emboflu Product
Table 99. Emboflu Recent Development
Table 100. BTG Corporation Information
Table 101. BTG Description and Major Businesses
Table 102. BTG Embolic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. BTG Product
Table 104. BTG Recent Development
Table 105. Cook Medical Corporation Information
Table 106. Cook Medical Description and Major Businesses
Table 107. Cook Medical Embolic Agents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Cook Medical Product
Table 109. Cook Medical Recent Development
Table 110. Global Embolic Agents Revenue Forecast by Region (2021-2026) (Million US$)
Table 111. Global Embolic Agents Production Forecast by Regions (2021-2026) (K Units)
Table 112. Global Embolic Agents Production Forecast by Type (2021-2026) (K Units)
Table 113. Global Embolic Agents Revenue Forecast by Type (2021-2026) (Million US$)
Table 114. North America Embolic Agents Consumption Forecast by Regions (2021-2026) (K Units)
Table 115. Europe Embolic Agents Consumption Forecast by Regions (2021-2026) (K Units)
Table 116. Asia Pacific Embolic Agents Consumption Forecast by Regions (2021-2026) (K Units)
Table 117. Latin America Embolic Agents Consumption Forecast by Regions (2021-2026) (K Units)
Table 118. Middle East and Africa Embolic Agents Consumption Forecast by Regions (2021-2026) (K Units)
Table 119. Embolic Agents Distributors List
Table 120. Embolic Agents Customers List
Table 121. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 122. Key Challenges
Table 123. Market Risks
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Embolic Agents Product Picture
Figure 2. Global Embolic Agents Production Market Share by Type in 2020 & 2026
Figure 3. Liquid Embolic Agents Product Picture
Figure 4. Particulate Embolic Agents Product Picture
Figure 5. Others Product Picture
Figure 6. Global Embolic Agents Consumption Market Share by Application in 2020 & 2026
Figure 7. Occlude Bleeding
Figure 8. Oncotherapy
Figure 9. Malignant Hypertension
Figure 10. Others
Figure 11. Embolic Agents Report Years Considered
Figure 12. Global Embolic Agents Revenue 2015-2026 (Million US$)
Figure 13. Global Embolic Agents Production Capacity 2015-2026 (K Units)
Figure 14. Global Embolic Agents Production 2015-2026 (K Units)
Figure 15. Global Embolic Agents Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 16. Embolic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Embolic Agents Production Share by Manufacturers in 2015
Figure 18. The Top 10 and Top 5 Players Market Share by Embolic Agents Revenue in 2019
Figure 19. Global Embolic Agents Production Market Share by Region (2015-2020)
Figure 20. Embolic Agents Production Growth Rate in North America (2015-2020) (K Units)
Figure 21. Embolic Agents Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 22. Embolic Agents Production Growth Rate in Europe (2015-2020) (K Units)
Figure 23. Embolic Agents Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 24. Embolic Agents Production Growth Rate in China (2015-2020) (K Units)
Figure 25. Embolic Agents Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 26. Embolic Agents Production Growth Rate in Japan (2015-2020) (K Units)
Figure 27. Embolic Agents Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 28. Global Embolic Agents Consumption Market Share by Regions 2015-2020
Figure 29. North America Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 30. North America Embolic Agents Consumption Market Share by Application in 2019
Figure 31. North America Embolic Agents Consumption Market Share by Countries in 2019
Figure 32. U.S. Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 33. Canada Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 34. Europe Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 35. Europe Embolic Agents Consumption Market Share by Application in 2019
Figure 36. Europe Embolic Agents Consumption Market Share by Countries in 2019
Figure 37. Germany Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 38. France Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. U.K. Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. Italy Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 41. Russia Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 42. Asia Pacific Embolic Agents Consumption and Growth Rate (K Units)
Figure 43. Asia Pacific Embolic Agents Consumption Market Share by Application in 2019
Figure 44. Asia Pacific Embolic Agents Consumption Market Share by Regions in 2019
Figure 45. China Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 46. Japan Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. South Korea Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. India Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. Australia Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Taiwan Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Indonesia Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Thailand Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Malaysia Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Philippines Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 55. Vietnam Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 56. Latin America Embolic Agents Consumption and Growth Rate (K Units)
Figure 57. Latin America Embolic Agents Consumption Market Share by Application in 2019
Figure 58. Latin America Embolic Agents Consumption Market Share by Countries in 2019
Figure 59. Mexico Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 60. Brazil Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 61. Argentina Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 62. Middle East and Africa Embolic Agents Consumption and Growth Rate (K Units)
Figure 63. Middle East and Africa Embolic Agents Consumption Market Share by Application in 2019
Figure 64. Middle East and Africa Embolic Agents Consumption Market Share by Countries in 2019
Figure 65. Turkey Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 66. Saudi Arabia Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 67. U.A.E Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 68. Global Embolic Agents Production Market Share by Type (2015-2020)
Figure 69. Global Embolic Agents Production Market Share by Type in 2019
Figure 70. Global Embolic Agents Revenue Market Share by Type (2015-2020)
Figure 71. Global Embolic Agents Revenue Market Share by Type in 2019
Figure 72. Global Embolic Agents Production Market Share Forecast by Type (2021-2026)
Figure 73. Global Embolic Agents Revenue Market Share Forecast by Type (2021-2026)
Figure 74. Global Embolic Agents Market Share by Price Range (2015-2020)
Figure 75. Global Embolic Agents Consumption Market Share by Application (2015-2020)
Figure 76. Global Embolic Agents Value (Consumption) Market Share by Application (2015-2020)
Figure 77. Global Embolic Agents Consumption Market Share Forecast by Application (2021-2026)
Figure 78. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 79. Terumo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Boston Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. Merit Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. GEM Italy Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. IMBiotechnologies Ltd?IMB? Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. Emboflu Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. BTG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Cook Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Global Embolic Agents Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 89. Global Embolic Agents Revenue Market Share Forecast by Regions ((2021-2026))
Figure 90. Global Embolic Agents Production Forecast by Regions (2021-2026) (K Units)
Figure 91. North America Embolic Agents Production Forecast (2021-2026) (K Units)
Figure 92. North America Embolic Agents Revenue Forecast (2021-2026) (US$ Million)
Figure 93. Europe Embolic Agents Production Forecast (2021-2026) (K Units)
Figure 94. Europe Embolic Agents Revenue Forecast (2021-2026) (US$ Million)
Figure 95. China Embolic Agents Production Forecast (2021-2026) (K Units)
Figure 96. China Embolic Agents Revenue Forecast (2021-2026) (US$ Million)
Figure 97. Japan Embolic Agents Production Forecast (2021-2026) (K Units)
Figure 98. Japan Embolic Agents Revenue Forecast (2021-2026) (US$ Million)
Figure 99. Global Embolic Agents Consumption Market Share Forecast by Region (2021-2026)
Figure 100. Embolic Agents Value Chain
Figure 101. Channels of Distribution
Figure 102. Distributors Profiles
Figure 103. Porter's Five Forces Analysis
Figure 104. Bottom-up and Top-down Approaches for This Report
Figure 105. Data Triangulation
Figure 106. Key Executives Interviewed
Figure 1. Embolic Agents Product Picture
Figure 2. Global Embolic Agents Production Market Share by Type in 2020 & 2026
Figure 3. Liquid Embolic Agents Product Picture
Figure 4. Particulate Embolic Agents Product Picture
Figure 5. Others Product Picture
Figure 6. Global Embolic Agents Consumption Market Share by Application in 2020 & 2026
Figure 7. Occlude Bleeding
Figure 8. Oncotherapy
Figure 9. Malignant Hypertension
Figure 10. Others
Figure 11. Embolic Agents Report Years Considered
Figure 12. Global Embolic Agents Revenue 2015-2026 (Million US$)
Figure 13. Global Embolic Agents Production Capacity 2015-2026 (K Units)
Figure 14. Global Embolic Agents Production 2015-2026 (K Units)
Figure 15. Global Embolic Agents Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 16. Embolic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Embolic Agents Production Share by Manufacturers in 2015
Figure 18. The Top 10 and Top 5 Players Market Share by Embolic Agents Revenue in 2019
Figure 19. Global Embolic Agents Production Market Share by Region (2015-2020)
Figure 20. Embolic Agents Production Growth Rate in North America (2015-2020) (K Units)
Figure 21. Embolic Agents Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 22. Embolic Agents Production Growth Rate in Europe (2015-2020) (K Units)
Figure 23. Embolic Agents Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 24. Embolic Agents Production Growth Rate in China (2015-2020) (K Units)
Figure 25. Embolic Agents Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 26. Embolic Agents Production Growth Rate in Japan (2015-2020) (K Units)
Figure 27. Embolic Agents Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 28. Global Embolic Agents Consumption Market Share by Regions 2015-2020
Figure 29. North America Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 30. North America Embolic Agents Consumption Market Share by Application in 2019
Figure 31. North America Embolic Agents Consumption Market Share by Countries in 2019
Figure 32. U.S. Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 33. Canada Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 34. Europe Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 35. Europe Embolic Agents Consumption Market Share by Application in 2019
Figure 36. Europe Embolic Agents Consumption Market Share by Countries in 2019
Figure 37. Germany Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 38. France Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. U.K. Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. Italy Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 41. Russia Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 42. Asia Pacific Embolic Agents Consumption and Growth Rate (K Units)
Figure 43. Asia Pacific Embolic Agents Consumption Market Share by Application in 2019
Figure 44. Asia Pacific Embolic Agents Consumption Market Share by Regions in 2019
Figure 45. China Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 46. Japan Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. South Korea Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. India Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. Australia Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Taiwan Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Indonesia Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Thailand Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Malaysia Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Philippines Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 55. Vietnam Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 56. Latin America Embolic Agents Consumption and Growth Rate (K Units)
Figure 57. Latin America Embolic Agents Consumption Market Share by Application in 2019
Figure 58. Latin America Embolic Agents Consumption Market Share by Countries in 2019
Figure 59. Mexico Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 60. Brazil Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 61. Argentina Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 62. Middle East and Africa Embolic Agents Consumption and Growth Rate (K Units)
Figure 63. Middle East and Africa Embolic Agents Consumption Market Share by Application in 2019
Figure 64. Middle East and Africa Embolic Agents Consumption Market Share by Countries in 2019
Figure 65. Turkey Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 66. Saudi Arabia Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 67. U.A.E Embolic Agents Consumption and Growth Rate (2015-2020) (K Units)
Figure 68. Global Embolic Agents Production Market Share by Type (2015-2020)
Figure 69. Global Embolic Agents Production Market Share by Type in 2019
Figure 70. Global Embolic Agents Revenue Market Share by Type (2015-2020)
Figure 71. Global Embolic Agents Revenue Market Share by Type in 2019
Figure 72. Global Embolic Agents Production Market Share Forecast by Type (2021-2026)
Figure 73. Global Embolic Agents Revenue Market Share Forecast by Type (2021-2026)
Figure 74. Global Embolic Agents Market Share by Price Range (2015-2020)
Figure 75. Global Embolic Agents Consumption Market Share by Application (2015-2020)
Figure 76. Global Embolic Agents Value (Consumption) Market Share by Application (2015-2020)
Figure 77. Global Embolic Agents Consumption Market Share Forecast by Application (2021-2026)
Figure 78. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 79. Terumo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Boston Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. Merit Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. GEM Italy Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. IMBiotechnologies Ltd?IMB? Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. Emboflu Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. BTG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Cook Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Global Embolic Agents Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 89. Global Embolic Agents Revenue Market Share Forecast by Regions ((2021-2026))
Figure 90. Global Embolic Agents Production Forecast by Regions (2021-2026) (K Units)
Figure 91. North America Embolic Agents Production Forecast (2021-2026) (K Units)
Figure 92. North America Embolic Agents Revenue Forecast (2021-2026) (US$ Million)
Figure 93. Europe Embolic Agents Production Forecast (2021-2026) (K Units)
Figure 94. Europe Embolic Agents Revenue Forecast (2021-2026) (US$ Million)
Figure 95. China Embolic Agents Production Forecast (2021-2026) (K Units)
Figure 96. China Embolic Agents Revenue Forecast (2021-2026) (US$ Million)
Figure 97. Japan Embolic Agents Production Forecast (2021-2026) (K Units)
Figure 98. Japan Embolic Agents Revenue Forecast (2021-2026) (US$ Million)
Figure 99. Global Embolic Agents Consumption Market Share Forecast by Region (2021-2026)
Figure 100. Embolic Agents Value Chain
Figure 101. Channels of Distribution
Figure 102. Distributors Profiles
Figure 103. Porter's Five Forces Analysis
Figure 104. Bottom-up and Top-down Approaches for This Report
Figure 105. Data Triangulation
Figure 106. Key Executives Interviewed
